两性寡核酸衍生物 - - 治疗药物的有前途的工具
Irina A Bauer1, Elena V Dmitrienko1
1Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.
Pharmaceutics
|November 27, 2024
概括
化学改性核酸,特别是脂质结合的寡核酸,提供向的疾病治疗. 研究探索它们的自我组装和与白蛋白的相互作用,以改善分娩和治疗效果.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药用化学 医学化学
背景情况:
- 遗传学和核酸化学为治疗,诊断和基因组编辑提供了新的工具.
- 核酸疗法可以选择性地针对疾病原因,但在药理动力学和生物活性方面面临挑战.
- 改善治疗性核酸的输送方法至关重要,重点是改性类似物和脂质生物结合物.
研究的目的:
- 审查化学改性核酸衍生物用于治疗应用的现状.
- 专注于与脂质部分结合的寡核酸,以增强交付.
- 分析两性寡核酸的自我组装及其与血清白蛋白的相互作用.
主要方法:
- 化学修饰核酸衍生物的系统分析.
- 研究自我组装到状结构中的方法.
- 对与血清白蛋白的非共价相互作用的评估.
主要成果:
- 改性核酸类似物和脂质生物结合物显示出药物输送的前景.
- 两性寡核酸可以自组装成类似菌的结构.
- 与血清白蛋白的相互作用影响生物分布和治疗结果.
结论:
- 化学修饰的核酸,特别是脂质结合的寡核酸,代表了向治疗的重大进步.
- 了解自我组装和白蛋白相互作用是优化药理动力学特性和治疗疗效的关键.
- 对这些改性核酸的进一步研究有可能改善疾病治疗.
相关概念视频
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
DNA Base Pairing
26.9K
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
26.9K
Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K


